The revision of the restrictive lists of medicinal products
Information about the new rules and the outcome of the revision of the four restrictive lists of medicaments are submitted. Lists of vital and essential medicines, «preferential» list of drugs prescribed by a decision of medical commissions, the list of expensive drugs and the list of drugs constitu...
Saved in:
Main Authors: | B. K. Romanov (Author), Yu. V. Olefir (Author), V. A. Merkulov (Author), Y. O. Pegova (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS
by: R. N. Alyautdin, et al.
Published: (2018) -
Inclusion drugs in the restrictive lists: step by step algorithm
by: E. V. Afanasyeva
Published: (2020) -
Revising the WHO Essential Medicines List for paediatric rheumatology
by: Christiaan Scott, et al.
Published: (2021) -
Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy
by: V. A. Lemeshko, et al.
Published: (2021) -
Revising the WHO Essential Medicines List for paediatric rheumatology update
by: Waheba Slamang, et al.
Published: (2022)